Samik Pharmaceutical Company LTD. (KOSDAQ:014950)

KOSDAQ:014950 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	4,551	2,074
Short-Term Investments	4,327	2,000
Trading Asset Securities	4,057	4,692
Cash & Short-Term Investments	12,935	8,766
Cash Growth	47.55%	-
Accounts Receivable	8,767	9,202
Other Receivables	146.74	69.57
Receivables	8,914	9,572
Inventory	11,982	9,976
Prepaid Expenses	2.13	2.44
Other Current Assets	295.98	340.98
Total Current Assets	34,129	28,658
Property, Plant & Equipment	24,963	25,389
Long-Term Investments	4,411	4,214
Other Intangible Assets	320.91	338.49
Long-Term Accounts Receivable	0	0
Long-Term Deferred Tax Assets	97.23	94.89
Other Long-Term Assets	387.51	337.51
Total Assets	64,309	59,032
Accounts Payable	1,742	1,490
Accrued Expenses	3,586	3,156
Current Portion of Leases	68.91	139.37
Current Income Taxes Payable	359.93	19.33
Other Current Liabilities	4,675	4,071
Total Current Liabilities	10,432	8,876
Long-Term Leases	23.81	57.15
Pension & Post-Retirement Benefits	37.12	18.47
Long-Term Deferred Tax Liabilities	1,778	1,642
Other Long-Term Liabilities	86.21	103.1
Total Liabilities	12,357	10,697
Common Stock	714.95	702.5
Additional Paid-In Capital	781.96	-
Retained Earnings	51,166	47,925
Comprehensive Income & Other	-711.02	-292.17
Shareholders' Equity	51,952	48,335
Total Liabilities & Equity	64,309	59,032
Total Debt	92.71	196.52
Net Cash (Debt)	12,842	8,570
Net Cash Growth	49.85%	-
Net Cash Per Share	1826.67	1220.83
Filing Date Shares Outstanding	7.03	7.02
Total Common Shares Outstanding	7.03	7.02
Working Capital	23,697	19,782
Book Value Per Share	7389.69	6885.80
Tangible Book Value	51,631	47,997
Tangible Book Value Per Share	7344.04	6837.58
Land	18,821	18,821
Buildings	7,890	7,884
Machinery	11,256	10,555
Construction In Progress	177.5	288.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.